Nektr Technologies Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Liquidation

Nektr Technologies General Information

Description

Developer of a synthetic compound designed for the treatment of several infectious diseases. The company has developed a patented synthetic antimicrobial topical pharmaceutical gel that has potent antibacterial and antifungal activity against all tested pathogens, regardless of their resistance profile which has been validated by a number of world-leading research institutes and the technology achieved through the sustained release of reactive oxygen species (ROS), enabling clients to get an area of anti-microbial resistance, nasal decontamination and medical device coatings.

Contact Information

Website
www.nektr.ie
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Finisklin Business and Technology Park
  • Sligo F91 HF66
  • Sligo
  • Ireland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Finisklin Business and Technology Park
  • Sligo F91 HF66
  • Sligo
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nektr Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Bankruptcy: Liquidation 20-Dec-2023 Completed Bankruptcy: Liquidation
6. Later Stage VC Cancelled Clinical Trials - Phase 3
5. Later Stage VC 06-May-2021 Completed Clinical Trials - Phase 3
4. Accelerator/Incubator Completed Pre-Clinical Trials
3. Early Stage VC 17-Apr-2019 Completed Pre-Clinical Trials
2. Early Stage VC 23-Mar-2018 $493K $493K Completed Startup
1. University Spin-Out 01-Dec-2017 Completed Startup
To view Nektr Technologies’s complete valuation and funding history, request access »

Nektr Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
To view Nektr Technologies’s complete cap table history, request access »

Nektr Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a synthetic compound designed for the treatment of several infectious diseases. The company has developed a
Drug Discovery
Sligo, Ireland
6 As of 2023

Cambridge, MA
 

Parsippany, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nektr Technologies Competitors (3)

One of Nektr Technologies’s 3 competitors is Spero Therapeutics, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Spero Therapeutics Formerly VC-backed Cambridge, MA
Melinta Therapeutics Private Equity-Backed Parsippany, NJ
Bausch Health Companies Corporation Laval, Canada
You’re viewing 3 of 3 competitors. Get the full list »

Nektr Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nektr Technologies FAQs

  • When was Nektr Technologies founded?

    Nektr Technologies was founded in 2016.

  • Where is Nektr Technologies headquartered?

    Nektr Technologies is headquartered in Sligo, Ireland.

  • What is the size of Nektr Technologies?

    Nektr Technologies has 6 total employees.

  • What industry is Nektr Technologies in?

    Nektr Technologies’s primary industry is Drug Discovery.

  • Is Nektr Technologies a private or public company?

    Nektr Technologies is a Private company.

  • What is Nektr Technologies’s current revenue?

    The current revenue for Nektr Technologies is .

  • How much funding has Nektr Technologies raised over time?

    Nektr Technologies has raised $2.79M.

  • Who are Nektr Technologies’s competitors?

    Spero Therapeutics, Melinta Therapeutics, and Bausch Health Companies are competitors of Nektr Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process